Abstract
Sodium-Glucose Cotransporter 2 Inhibitors Confer Favourable Lipid Profiles in Hospitalised Patients With Coronary Artery Disease
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have